285 Shares in Humana Inc. (NYSE:HUM) Bought by Eastern Bank

Eastern Bank purchased a new position in shares of Humana Inc. (NYSE:HUM) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 285 shares of the insurance provider’s stock, valued at approximately $90,000.

A number of other institutional investors also recently bought and sold shares of HUM. CarsonAllaria Wealth Management Ltd. increased its stake in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. purchased a new stake in shares of Humana in the third quarter valued at about $29,000. Hantz Financial Services Inc. purchased a new stake in shares of Humana in the second quarter valued at about $35,000. Family Firm Inc. purchased a new stake in shares of Humana in the second quarter valued at about $37,000. Finally, Hollencrest Capital Management purchased a new stake in shares of Humana in the second quarter valued at about $40,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research analyst reports. Bank of America downgraded shares of Humana from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $376.00 to $247.00 in a report on Wednesday, October 2nd. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Royal Bank of Canada decreased their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. TD Cowen downgraded shares of Humana from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $402.00 to $261.00 in a report on Monday, October 7th. Finally, Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target on the stock in a report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $315.33.

Humana Stock Performance

Shares of HUM stock opened at $260.73 on Friday. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The company has a 50 day moving average price of $308.31 and a 200 day moving average price of $336.88. The firm has a market capitalization of $31.39 billion, a price-to-earnings ratio of 18.60, a price-to-earnings-growth ratio of 2.04 and a beta of 0.50.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter last year, the firm posted $8.94 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Sell-side analysts anticipate that Humana Inc. will post 16.06 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 25.25%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.